#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency Choroidal dystrophy Usher's syndrome Acquired haemophilia Isodicentric chromosome 15 syndrome Hereditary angioedema Medulloblastoma Arterial disorder Gastrointestinal neuroendocrine tumour Turner's syndrome Advanced systemic mastocytosis Pemphigoid Pelizaeus-Merzbacher disease Inborn error of metabolism Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Basic Information CADASIL – Life with Disease Osteosarcoma – Basic Information Biotinidase deficiency – Basic Information Arterial tortuosity syndrome – Basic Information Epidermolysis bullosa – Trials in Disease Fragile X syndrome – Treatment Waldenstrom’s macroglobulinaemia – Trials in Disease Wiskott-Aldrich syndrome – Life with Disease Chronic granulomatous disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cytarabine Tramazoline Hydrochloride Azelastine Molidustat Sodium Bendamustine Nitric Oxide Ly3819469 Sodium Vilanterol Bi 706321 Mometasone Furoate Amoxicillin Ly3454738 Isoniazid Disodium Levofolinate Utreloxastat Resmetirom Redasemtide Montelukast Sodium Azelastine Hydrochloride Lenacapavir Sodium More therapies…

    Learn about Your Condition

    Nodular melanoma Pulmonary embolism Neurodermatitis Infectious pleural effusion Ovarian epithelial cancer Pituitary tumour benign Leukocyte adhesion deficiency Friedreich's ataxia Lymphocytic lymphoma Obesity Juvenile spondyloarthritis Nervous system disorder Overweight Generalised anxiety disorder Migraine with aura More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Atrial fibrillation

  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Colchicine
    Germany

  • A study on the effect of hydrogen inhalation therapy to prevent the early return of atrial fibrillation in patients after heart ablation treatment.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • HYDROGEN
    France

  • A Study of Semaglutide in Overweight or Obese Patients with Atrial Fibrillation Scheduled for Catheter Ablation to Improve Treatment Outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Semaglutide
    Sweden

  • Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Propafenone Hydrochloride
    Latvia

  • Study of acetylsalicylic acid and clopidogrel treatment duration after left atrial appendage closure in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    Poland

  • Study Comparing Dabigatran Etexilate, Acetylsalicylic Acid, and Clopidogrel for Preventing Blood Clots in Patients with Atrial Fibrillation After Heart Procedure

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Dabigatran Etexilate
    • Clopidogrel
    • Acetylsalicylic Acid
    Spain
Previous Page
1 … 4 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!